Shares of Reckitt Benckiser Group plc (OTCMKTS:RBGLY – Get Free Report) have earned an average recommendation of “Buy” from the eight analysts that are currently covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a hold rating, two have issued a buy rating and three have assigned a strong buy rating to the company.
Several analysts have commented on the stock. Barclays lowered shares of Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a research report on Tuesday, February 4th. Hsbc Global Res raised shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, December 11th. Royal Bank of Canada reissued an “outperform” rating on shares of Reckitt Benckiser Group in a research note on Friday, March 7th. Finally, HSBC raised shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research note on Wednesday, December 11th.
Get Our Latest Stock Report on RBGLY
Reckitt Benckiser Group Stock Down 0.1 %
Reckitt Benckiser Group Increases Dividend
The firm also recently declared a dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 11th will be paid a $0.2909 dividend. This is a positive change from Reckitt Benckiser Group’s previous dividend of $0.19. The ex-dividend date of this dividend is Friday, April 11th.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Further Reading
- Five stocks we like better than Reckitt Benckiser Group
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Pros And Cons Of Monthly Dividend Stocks
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Consumer Discretionary Stocks Explained
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.